The Role of MUC1 in Renal Cell Carcinoma
Martina Milella(University of Bari Aldo Moro), Giuseppe Lucarelli(University of Bari Aldo Moro), Francesco Lasorsa(University of Bari Aldo Moro), Michele Battaglia(Mater Dei Hospital), Marco Spilotros(University of Bari Aldo Moro), Pasquale Ditonno(University of Bari Aldo Moro), Felice Crocetto(University of Naples Federico II), Monica Rutigliano(University of Bari Aldo Moro), Giuseppe Fallara(Istituti di Ricovero e Cura a Carattere Scientifico), Savio Domenico Pandolfo(University of Salerno), Antonio d’Amati(Università Cattolica del Sacro Cuore), Biagio Barone(Ospedale San Paolo), Roberto Bianchi(Istituti di Ricovero e Cura a Carattere Scientifico), Matteo Ferro(European Institute of Oncology)
Cited by 59
Related Papers
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
|International Journal of Molecular Sciences|2022|190
Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice
|Biomedicines|2023|161
Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management—Current Trends and Future Perspectives
|Diagnostics|2021|158
Association of NAFLD and Insulin Resistance with Non Metastatic Bladder Cancer Patients: A Cross-Sectional Retrospective Study
|Journal of Clinical Medicine|2021|131